November 3, 2017 - Posts

Cancer Drug Taxotere Linked to Permanent Hair Loss

Our firm represents clients who have suffered permanent hair loss as a result of taking Taxotere.

What is Taxotere?

Taxotere (docetaxel) is an anti-cancer chemotherapy drug that has been approved by the FDA to treat breast cancer, non-small cell lung cancer, prostate cancer, stomach cancer, and head and neck cancer.  The drug is administered by an infusion through a vein, typically every 3 weeks.  Taxotere works by attacking cancer cells in the body, preventing them from growing and dividing.

Taxotere and Permanent Hair Loss

While hair loss is a common side effect of chemotherapy, many patients who were treated with Taxotere suffered hair loss that was permanent (alopecia).  There is mounting evidence that suggests that Sanofi-Aventis, the manufacturers of Taxotere, failed to warn patients and physicians of the increased risks of permanent hair loss as a result of being treated with Taxotere.

If you or a loved one has suffered from permanent hair loss after being treated with Taxotere, we urge you to contact our firm for a free case review.

For more information about our Defective Drugs & Devices practice area, click here.